摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二甲基苯并噻吩 | 4923-91-5

中文名称
2,3-二甲基苯并噻吩
中文别名
——
英文名称
2,3-dimethylbenzothiophene
英文别名
2,3-dimethylbenzothiophene;2,3-dimethylbenzo[b]thiophene;2,3-dimethylbenzo{b}thiophene;2,3-methylbenzo[b]thiophene;2,3-dimethyl-benzo[b]thiophene;Benzo(b)thiophene, 2,3-dimethyl-;2,3-dimethyl-1-benzothiophene
2,3-二甲基苯并噻吩化学式
CAS
4923-91-5
化学式
C10H10S
mdl
MFCD00216252
分子量
162.255
InChiKey
ACHMHHCOSAKQSS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    122-124 °C(Press: 13 Torr)
  • 密度:
    1.1054 g/cm3
  • 保留指数:
    1435.4

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:911a5216dbd675ea6c42d1e7cd0d88a1
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3-二甲基苯并噻吩双氧水 作用下, 以 溶剂黄146 为溶剂, 反应 0.25h, 生成 1,1-dioxo-2,3-dimethylbenzothiophene
    参考文献:
    名称:
    Transformations of six isomers of dimethylbenzothiophene by three Pseudomonas strains
    摘要:
    Dimethylbenzothiophenes are among the sulfur heterocycles in petroleum that are known to be degraded by microbial activity. Six of the 15 possible isomers of dimethylbenzothiophene were synthesized and used in biotransformation studies with three Pseudomonas isolates that oxidize a variety of condensed thiophenes including methylbenzothiophenes and methyldibenzothiophenes. The isomers of dimethylbenzothiophene were chosen to have a variety of substitution patterns: both methyl groups on the thiophene ring (the 2,3-isomer); a methyl group on each of the rings (the 2,7-, 3,5- and 3,7-isomers); and both methyl groups on the benzene ring (the 4,6- and 4,7-isomers). Each isolate was grown on l-methylnaphthalene or glucose in the presence of one of the dimethylbenzothiophenes and culture extracts were analyzed to identify nearly 30 sulfur-containing metabolites in total. Sulfoxides and sulfones were commonly found metabolites in culture extracts from the 2,3-, 2,7- and 3,7-isomers, whereas 2,3-diones, 3(2H)-ones and 2(3H)-ones were formed from the 4,6- and 4,7-isomers. High-molecular-weight products, some of which were tentatively identified as tetramethylbenzo[b]naphtho[1,2-d]thiophen were detected in the extracts of cultures incubated with 4,6- or 4,7-dimethylbenzothiophene. The methyl groups of all of the isomers, except 4,6-, were oxidized to give hydroxymethyl-methylbenzothiophenes and methylbenzothiophene-carboxylic acids, and these were the only products detected from the oxidation of 3,5-dimethylbenzothiophene.
    DOI:
    10.1007/bf00058180
  • 作为产物:
    描述:
    2-甲基-2-(苯基巯基)丙醛 在 triethyloxonium fluoroborate 作用下, 以 二氯甲烷 为溶剂, 以85%的产率得到2,3-二甲基苯并噻吩
    参考文献:
    名称:
    Groot, Aede de; Jansen, Ben J. M., Synthesis, 1985, # 4, p. 434 - 436
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF STRESS-RELATED CONDITIONS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LE TRAITEMENT D'ÉTATS LIÉS AU STRESS
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2010137738A1
    公开(公告)日:2010-12-02
    The present invention provides a novel heterocyclic compound. A heterocyclic compound represented by general formula (1) wherein, R1 and R2, each independently represent hydrogen; a phenyl lower alkyl group that may have a substituent(s) selected from the group consisting of a lower alkyl group and the like on a benzene ring and/or a lower alkyl group; or a cyclo C3-C8 alkyl lower alkyl group; or the like; R3 represents a lower alkynyl group or the like; R4 represents a phenyl group that may have a substituent(s) selected from the group consisting of a 1,3,4-oxadiazolyl group that may have e.g., halogen or a heterocyclic group selected from pyridyl group and the like; the heterocyclic group may have at least one substituent(s) selected from a lower alkoxy group and the like or a salt thereof.
    本发明提供了一种新颖的杂环化合物。一种由通式(1)表示的杂环化合物,其中,R1和R2分别独立表示基较低烷基基团,可能在环和/或较低烷基基团上具有从较低烷基基团等组成的取代基;或环C3-C8烷基较低烷基基团;或类似物;R3表示较低炔基基团或类似物;R4表示可能具有从1,3,4-噁二唑基团(例如,卤素)或从吡啶基团等组成的取代基的基团;所述杂环基可能具有至少一个从较低烷基等选择的取代基或其盐。
  • Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
    申请人:Maeda Dean Y.
    公开号:US20100210593A1
    公开(公告)日:2010-08-19
    There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.
    披露了作为药物剂的吡啶嘧啶酰胺化合物,合成过程以及包括吡啶嘧啶酰胺化合物的药物组合物。更具体地,披露了一类CXCR2抑制剂化合物,可用于治疗各种炎症和肿瘤性疾病。
  • THIADIAZOLE ANALOGS THEREOF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED-CONDITIONS
    申请人:AXFORD Jake
    公开号:US20140206661A1
    公开(公告)日:2014-07-24
    The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了一种公式(X)的化合物或其药用盐;一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药物活性剂的组合物和一种药物组合物。
  • Pyridobenzazepine compounds and methods for inhibiting mitotic progression
    申请人:Claiborne F. Christopher
    公开号:US20080045501A1
    公开(公告)日:2008-02-21
    This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treatment of cancer.
    这项发明涉及用于治疗癌症的化合物和方法。具体而言,该发明提供了抑制枢纽激酶的化合物,包括这些化合物的药物组合物,以及使用这些化合物治疗癌症的方法。
  • [EN] MACROCYCLIC AND BICYCLIC INHIBITORS OF HEPATITIS C VIRUS<br/>[FR] INHIBITEURS MACROCYCLIQUES ET BICYCLIQUES DU VIRUS DE L'HÉPATITE C
    申请人:GILEAD SCIENCES INC
    公开号:WO2014145095A1
    公开(公告)日:2014-09-18
    Compounds of formula (I):or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.
    式(I)的化合物或其药用可接受的盐,其中各种取代基在此定义,使用所述化合物的方法,以及含有所述化合物的药物组合物。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

齐留通钠 齐留通相关物质A 齐留通亚砜 齐留通-d4 齐留通 雷洛昔芬杂质 邻联甲苯胺砜 试剂4,8-Bis(3,5-dioctyl-2-thienyl)-2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[1,2-b:4,5-b']dithiophene 试剂1,1'-[4,8-Bis[4-(2-ethylhexyl)-3,5-difluorophenyl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]bis[1,1,1-trimethylstannane] 苯并噻吩-7-醇 苯并噻吩-4-硼酸频哪醇酯 苯并噻吩-3-羧酸甲酯 苯并噻吩-3-硼酸 苯并噻吩-2-羰酰氯 苯并噻吩-2-羧酸肼 苯并噻吩-2-羧酸 苯并噻吩-2-硼酸 苯并噻吩-2-氨基甲酸叔丁酯 苯并噻吩 苯并[c]噻吩 苯并[b]噻吩-7-胺 苯并[b]噻吩-7-羧酸乙酯 苯并[b]噻吩-7-甲醛 苯并[b]噻吩-7-甲腈 苯并[b]噻吩-6-醇 苯并[b]噻吩-6-胺 苯并[b]噻吩-6-羧酸乙酯 苯并[b]噻吩-6-羧酸 苯并[b]噻吩-6-甲腈 苯并[b]噻吩-5-甲腈,2-甲酰基- 苯并[b]噻吩-5-甲磺酰氯 苯并[b]噻吩-4-羧酸甲酯 苯并[b]噻吩-4-羧酸 苯并[b]噻吩-4-甲醛 苯并[b]噻吩-4-甲腈 苯并[b]噻吩-4-基甲醇 苯并[b]噻吩-3-胺盐酸盐 苯并[b]噻吩-3-胺 苯并[b]噻吩-3-羧酸-(2-二烯丙基氨基乙酯) 苯并[b]噻吩-3-硼酸频哪酯 苯并[b]噻吩-3-甲醛肟 苯并[b]噻吩-3-甲酰胺 苯并[b]噻吩-3-基乙酸酯 苯并[b]噻吩-3-乙酸 苯并[b]噻吩-3-乙酰氯 苯并[b]噻吩-3-乙腈 苯并[b]噻吩-2-胺盐酸盐 苯并[b]噻吩-2-羧酸6-氨基-3-氯-甲酯 苯并[b]噻吩-2-羧酸,5-氯-3-(1-甲基乙氧基)- 苯并[b]噻吩-2-羧酸,3-羟基-5-甲氧基-,甲基酯